Sort
30,917 grants matching “tumor microenvironment”
Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface
$444,255Stefani Spranger · Massachusetts Institute Of Technology · U54 · FY2025 · CA
Chemical Probes for In Vivo Fibrin Imaging
$444,129Zhaoda Zhang · Massachusetts General Hospital · R01 · FY2016 · CA
Pregnancy, Obesogenic Environments, and Basal-like Breast Cancer
$444,000Melissa A. Troester · Univ Of North Carolina Chapel Hill · U01 · FY2010 · ES
B7-H1/PD-1 modulation in cancer therapy
$443,937Drew M. Pardoll · Johns Hopkins University · R01 · FY2014 · CA
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
$443,868Bhuvaneswari Ramaswamy · Ohio State University · R01 · FY2021 · CA
G-Quadruplex-Based Supramolecular Assemblies as Activatable Contrast Agents for In Vitro and In Vivo Fluorescence Imaging of Estrogen Receptor
$443,850John R Hawse · Mayo Clinic Rochester · R21 · FY2025 · EB
Non-invasive Quantification of Dose-Exposure-Response of PD-L1 Therapeutics at the Tumor
$443,812Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2019 · CA
Collaborative Innate-Adaptive Immune Regulation of Tumor Progression
$443,678Matthew F Krummel · University Of California, San Francisco · U01 · FY2011 · CA
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
$443,656Jlenia Guarnerio · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Reprogramming the Tumor Microenvironment in Ovarian Cancer
$443,654David D Schlaepfer · University Of California, San Diego · R01 · FY2020 · CA
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$443,645Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2021 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$443,645Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2020 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$443,645Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2019 · NS
Targeting Chemotherapy-induced Breast Cancer Stemness
$443,640Shizhen Emily Wang · University Of California, San Diego · R01 · FY2021 · CA
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
$443,607Martin G Pomper · Johns Hopkins University · R01 · FY2022 · CA
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$443,556Xinna Zhang · Indiana University Indianapolis · R01 · FY2024 · CA
Elucidating the role of the Branched Chain Aminotransferases (BCATc and BCATm) as novel metabolic checkpoints of anti-lymphoma T cell immunity
$443,548Elitsa Antonova Ananieva-Stoyanova · Des Moines Univ Osteopathic Medical Ctr · R15 · FY2021 · CA
Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
$443,479Wenbin Lin · University Of Chicago · R01 · FY2024 · CA
Prostate Section
$443,471Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Regulation of Signaling Receptor Activity by LRP-1
$443,423Steven L. Gonias · University Of California, San Diego · R01 · FY2012 · HL
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$443,412Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma
$443,412Reuben J Shaw · Salk Institute For Biological Studies · P01 · FY2024 · CA
Two-Photon Microscopy System
$443,392New York University School Of Medicine · S10 · FY2002 · RR
Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes
$443,381A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
$443,326Michael M. Shen · Columbia University Health Sciences · P01 · FY2025 · CA